Anemia, Sickle Cell × Clear all
NCT01758042 2026-03-06

BMT

Massachusetts General Hospital

Phase NA Completed
10 enrolled
NCT06098755 2026-02-04

The Sequestration of Holistic Stress Management Techniques for Adults

Virtual Tribunal Monastery

Phase NA Withdrawn
NCT01881334 2025-11-20

Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants

Duke University

Available
NCT05687474 2025-08-12

BabyDetect

Centre Hospitalier Universitaire de Liege

Completed
6,824 enrolled
NCT03333486 2025-07-04

Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer

Roswell Park Cancer Institute

Phase 2 Terminated
31 enrolled 18 charts
NCT03655223 2025-04-04

Early Check: Expanded Screening in Newborns

RTI International

Enrolling by invitation
30,000 enrolled
NCT06539169 2024-11-14

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

xCures

Recruiting
1,000 enrolled
NCT02061800 2024-06-04

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Columbia University

Phase 1/2 Active not recruiting
14 enrolled
NCT05635266 2024-05-07

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Sanguine Biosciences

Recruiting
20,000 enrolled
NCT01931644 2024-04-18

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Sanguine Biosciences

Completed
17,667 enrolled
NCT06072287 2023-10-12

LTC

King's College London

Unknown
600 enrolled
NCT02065869 2023-09-29

Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant

Bellicum Pharmaceuticals

Phase 1/2 Terminated
187 enrolled 8 charts
NCT03733249 2023-09-26

Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study

Bellicum Pharmaceuticals

Phase 1/2 Terminated
187 enrolled 8 charts
NCT03944447 2022-06-02

OMNI-Can

OMNI Medical Services, LLC

Phase 2 Unknown
200,000 enrolled